日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessment of the effectiveness of tocilizumab on mortality and progression to mechanical ventilation or intensive care in patients with COVID-19 admitted to a tertiary hospital

评估托珠单抗对入住三级医院的 COVID-19 患者死亡率以及进展至机械通气或重症监护的疗效

Pinilla Rello, Andrea; Magallón Martínez, Arantxa; Vicente Iturbe, Cristina; Escolano-Pueyo, Angel; Herranz Bayo, Elena; Aguilo Lafarga, Irene

[Pharmacokinetic monitoring of isavuconazole in a patient with extracorporeal membrane oxygenation support]

[体外膜肺氧合支持患者异沙康唑的药代动力学监测]

Herranz-Bayo, E; Huarte-Lacunza, R; Sánchez-Chueca, P; Aguiló-Lafarga, I; Pinilla-Rello, A; Sampedro-Calavia, E

[Extensively drug-resistant tuberculosis treated with bedaquiline]

[广泛耐药结核病用贝达喹啉治疗]

López Pérez, A; Navarro Aznarez, H; Pinilla Rello, A; Perales Pascual, J; Arazo Garcés, P

[Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact]

[抗逆转录病毒疗法的时间演变(2017-2021):治疗变化及其经济影响分析]

Herranz-Bayo, E; Navarro-Aznárez, H; Pinilla-Rello, A; Díaz-Calderón-Horcada, C I

[Adequacy of the consumption of antipseudomonal antibiotics after changes in the 2019 EUCAST criteria]

[2019 年 EUCAST 标准变更后抗假单胞菌抗生素使用情况的充分性]

Herranz-Bayo, E; Huarte-Lacunza, R; Pinilla-Rello, A; Aguiló-Lafarga, I; López-Calleja, A I

[Utilization study in real clinical practice of ceftolozane/tazobactam vs aminoglycosides and/or colistin in the treatment of multirresistant or extremely resistant Pseudomonas aeruginosa]

[头孢洛扎/他唑巴坦与氨基糖苷类和/或粘菌素在治疗多重耐药或极度耐药铜绿假单胞菌的真实临床应用研究]

Pinilla-Rello, A; Huarte-Lacunza, R; Magallón-Martínez, A; Cazorla-Poderoso, L; Pereira-Blanco, O; Pérez-Moreno, M; Larrodé-Leciñena, I; Martínez-Álvarez, R M; López-Calleja, A I